Ozempic, Wegovy covered by Medicare and Medicaid under Biden admin proposal for anti-obesity GLP-1 drugs
By Greg Norman for Fox News on November 26, 2024 The Biden administration is expanding coverage of anti-obesity drugs such as Ozempic
Read MoreBy Greg Norman for Fox News on November 26, 2024 The Biden administration is expanding coverage of anti-obesity drugs such as Ozempic
Read MoreBy Christy Bieber for Moneywise on November 23, 2024 Hindsight is 20-20, but for one 85-year-old retiree, the discovery that
Read More(By Phil Galewitz for KFF Health News) Nearly a year after the Biden administration gave Florida the green light to
Read More(Juliette Cubanski for The Kaiser Family Foundation Published: Nov 19, 2024) The Inflation Reduction Act of 2022 (the Act), signed
Read More(By Kelly Gooch for Becker’s Hospital Review) U.S. News & World Report has recognized seven Medicare Advantage and Medicare Part
Read More(By Paige Twenter for Becker’s Hospital Review) As CVS, Walgreens and Rite Aid close hundreds of pharmacies across the U.S.
Read More(By Sydney Lupkin for NPR) Ozempic and similar drugs for Type 2 diabetes and weight loss are in such high
Read More(By Alexandra Murphy for Becker’s Hospital Review) As President-elect Donald Trump prepares to take office, the future of Medicare’s drug
Read More(By Meredith Freed, Jeannie Fuglesten Biniek, Anthony Damico, and Tricia Neuman for The Kaiser Family Foundation Published: Nov 15, 2024)
Read More(By Rylee Wilson for Becker’s Hospital Review) Fewer Medicare Advantage insurers will offer remote access technologies and over-the-counter benefits in
Read More